Immune Pathways in Systemic Lupus Erythematosus (SLE)
[themo_button text=”Participate Now” url=”https://www.cmeoutfitters.com/transfers/cm/?ID=43769″ type=”standard” target=”_blank”] |
The first episode of this CMEOCast podcast series on systemic lupus erythematosus (SLE) focuses on the heterogeneity of lupus, including the multiple immune pathways that are active in it and how knowledge of immunopathogenesis has informed drug development. |
Safety and Efficacy of Emerging Treatments in the Management of Systemic Lupus Erythematosus (SLE)
[themo_button text=”Participate Now” url=”https://www.cmeoutfitters.com/transfers/cm/?ID=43770″ type=”standard” target=”_blank”] |
The future is bright for patients with lupus, as drug development activities are currently unprecedented. In this CMEOCast podcast episode, expert faculty evaluate the safety and efficacy of these emerging therapies. |
Improving the Application of Shared Decision-Making in the Selection of SLE Treatments
[themo_button text=”Participate Now” url=”https://www.cmeoutfitters.com/transfers/cm/?ID=43761″ type=”standard” target=”_blank”] |
The final episode in this CMEOCast podcast series on SLE addresses the impact and burden of SLE on quality of life, the integration of PROs when caring for patients with SLE, and the implementation of best practices for SDM in order to engage patients as partners in their care. |